108 related articles for article (PubMed ID: 11569702)
1. Dendroaspis natriuretic peptide in hepatic cirrhosis.
Fábrega E; Crespo J; Rivero M; Casafont F; Castro B; García-Unzueta MT; Amado JA; Pons-Romero F
Am J Gastroenterol; 2001 Sep; 96(9):2724-9. PubMed ID: 11569702
[TBL] [Abstract][Full Text] [Related]
2. Plasma adrenomedullin levels in patients with hepatic cirrhosis.
Fábrega E; Casafont F; Crespo J; de la Peña J; San Miguel G; de las Heras G; García-Unzueta MT; Amado JA; Pons-Romero F
Am J Gastroenterol; 1997 Oct; 92(10):1901-4. PubMed ID: 9382062
[TBL] [Abstract][Full Text] [Related]
3. Relationship of plasma Dendroaspis natriuretic peptide-like immunoreactivity and echocardiographic parameters in chronic haemodialysis patients.
Lee S; Park SK; Kang KP; Kang SK; Kim SZ; Kim W
Nephrology (Carlton); 2004 Jun; 9(3):171-5. PubMed ID: 15189179
[TBL] [Abstract][Full Text] [Related]
4. Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure.
Schirger JA; Heublein DM; Chen HH; Lisy O; Jougasaki M; Wennberg PW; Burnett JC
Mayo Clin Proc; 1999 Feb; 74(2):126-30. PubMed ID: 10069348
[TBL] [Abstract][Full Text] [Related]
5. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
Chen YX; Wang SC; Zhao GN; Tang J; Zhang SX; Tang CS
Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites.
Bonkovsky HL; Hartle DK; Mellen BG; Kutner M; Galambos JT
Am J Gastroenterol; 1988 May; 83(5):531-5. PubMed ID: 2966574
[TBL] [Abstract][Full Text] [Related]
7. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites.
Jiménez W; Gutkowska J; Ginés P; Arroyo V; Rivera F; Rodés J
Hepatology; 1991 Oct; 14(4 Pt 1):601-7. PubMed ID: 1833302
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of urodilatin in patients with cirrhosis.
Saló J; Jiménez W; Kuhn M; Ginès A; Ginès P; Fernández-Esparrach G; Angeli P; Clària J; Bataller R; Arroyo V; Forssmann WG; Rodés J
Hepatology; 1996 Dec; 24(6):1428-32. PubMed ID: 8938175
[TBL] [Abstract][Full Text] [Related]
9. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
[TBL] [Abstract][Full Text] [Related]
10. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
Wong F; Siu S; Liu P; Blendis LM
Clin Sci (Lond); 2001 Dec; 101(6):621-8. PubMed ID: 11724649
[TBL] [Abstract][Full Text] [Related]
11. Dendroaspis natriuretic peptide and its functions in pig ovarian granulosa cells.
Piao FL; Park SH; Han JH; Cao C; Kim SZ; Kim SH
Regul Pept; 2004 May; 118(3):193-8. PubMed ID: 15003836
[TBL] [Abstract][Full Text] [Related]
12. Daily profile of circulating C-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects: relationship with renal function.
Zambruni A; Trevisani F; Gülberg V; Caraceni P; Domenicali M; Cantarini MC; Cappa FM; Di Micoli A; Magini G; Labate-Morselli AM; Gerbes AL; Bernardi M
Scand J Gastroenterol; 2007 May; 42(5):642-7. PubMed ID: 17454886
[TBL] [Abstract][Full Text] [Related]
13. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
14. Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor.
Johns DG; Ao Z; Heidrich BJ; Hunsberger GE; Graham T; Payne L; Elshourbagy N; Lu Q; Aiyar N; Douglas SA
Biochem Biophys Res Commun; 2007 Jun; 358(1):145-9. PubMed ID: 17475216
[TBL] [Abstract][Full Text] [Related]
15. Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients.
Radvan M; Svoboda P; Radvanová J; Stumar J; Scheer P
Hepatogastroenterology; 2009; 56(89):181-5. PubMed ID: 19453054
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
Kawasaki H; Uemasu J; Maeda N; Hirayama C; Kobayashi T; Sakurai H
Am J Gastroenterol; 1987 Aug; 82(8):727-31. PubMed ID: 3037881
[TBL] [Abstract][Full Text] [Related]
17. The atrial natriuretic peptide-renin-aldosterone system in hepatorenal syndrome.
Pasqualetti P; Casale R
Riv Eur Sci Med Farmacol; 1996; 18(4):137-41. PubMed ID: 9177611
[TBL] [Abstract][Full Text] [Related]
18. Renal actions of synthetic dendroaspis natriuretic peptide.
Lisy O; Jougasaki M; Heublein DM; Schirger JA; Chen HH; Wennberg PW; Burnett JC
Kidney Int; 1999 Aug; 56(2):502-8. PubMed ID: 10432389
[TBL] [Abstract][Full Text] [Related]
19. Dendroaspis natriuretic peptide system and its paracrine function in rat colon.
Kim JH; Yang SH; Yu MY; Lee HK; Kim SY; Kim SH
Regul Pept; 2004 Aug; 120(1-3):93-8. PubMed ID: 15177925
[TBL] [Abstract][Full Text] [Related]
20. Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
Lo GH; Lam HC; Cheng JT; Lin JK; Hsu JH; Lai KH; Chiang HT
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):596-602. PubMed ID: 9830237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
